Hard to Resist This Market

It never came in. Not one day. That's what I think about when I look at New River Pharma (NRPH - commentary - Cramer's Take). The moment when the full potential for New River's ADHD treatment surfaced, it was all over. The stock just wouldn't quit.

I know when a stock goes from $26 to $48 on a new drug, you have to expect that it will retrace some of the move. Isn't that what the short-sellers are saying right now -- and have been for days -- in Onyx (ONXX - commentary - Cramer's Take), the company with the liver-cancer drug?

But sometimes the market knows more than we think. Shire (SHPGY - commentary - Cramer's Take) needed this more than we ever believed. Maybe Bayer needs Onyx more than we think.

I thought people should sell New River in the $50s, believing that some of this move had to be hype. I misread Shire's situation, not the New River situation. I didn't know Shire was desperate. Because Shire didn't wait for a pullback, you got known.

You know what the takeaway is here?

In some stages of the bull market, the corporations throw caution to the wind. Which is why this is such a hard market to resist... and you can't leave the table.

At the time of publication, Cramer had no positions in any of the stocks mentioned.

ALL JIM CRAMER BLOG ENTRIES | POST A COMMENT | READ COMMENTS  

---

Jim Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for Action Alerts PLUS. Watch Cramer on "Mad Money" weeknights on CNBC. Click here to order Cramer's latest book, "Mad Money: Watch TV, Get Rich," click here to order his book, "Real Money: Sane Investing in an Insane World," click here to get his second book, "You Got Screwed!" and click here to order Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by clicking here.

TheStreet.com has a revenue-sharing relationship with Traders' Library under which it receives a portion of the revenue from Traders' Library purchases by customers directed there from TheStreet.com.